Search results
Results from the WOW.Com Content Network
President Duterte during a meeting with members of the IATF-EID at the Matina Enclaves in Davao City in June 2020. The COVID-19 Immunization Program Management Organizational Structure was formed on October 26, 2020, to facilitate the distribution of COVID-19 vaccines in the Philippines, however this was replaced by a vaccine cluster within the Inter-Agency Task Force for the Management of ...
The Philippines is set to sign a supply agreement for AstraZeneca's potential COVID-19 vaccine on Friday, the first such deal in a country aiming to further reopen its economy that has been ...
With nearly 2.8 million COVID-19 cases and almost 42,000 deaths, the Philippines has the second-highest infections and fatalities in Southeast Asia. Philippines to start vaccine mixing trials by ...
National regulatory authorities have granted full or emergency use authorizations for 40 COVID-19 vaccines.. Ten vaccines have been approved for emergency or full use by at least one stringent regulatory authority recognized by the World Health Organization (WHO): Pfizer–BioNTech, Oxford–AstraZeneca, Sinopharm BIBP, Moderna, Janssen, CoronaVac, Covaxin, Novavax, Convidecia, and Sanofi ...
Philippine health authorities on Wednesday allowed the use of Sinovac's COVID-19 vaccine for some senior citizens after initially limiting coverage to people aged 18-59 years, as the country ...
The Sinopharm WIBP COVID-19 vaccine, also known as WIBP-CorV, [2] [3] is one of two inactivated virus COVID-19 vaccines developed by Sinopharm. Peer-reviewed results show that the vaccine is 72.8% effective against symptomatic cases and 100% against severe cases (26 cases in vaccinated group vs. 95 cases in placebo group). [ 4 ]
Philippines President Rodrigo Duterte received his first dose of Sinopharm's vaccine against COVID-19 on Monday to encourage reluctant Filipinos to get inoculated and help stop the spread of the ...
The purpose of this study is to determine if the investigational COVID-19 vaccines are safe and can stimulate and broaden the immune response against the different COVID-19 variants that cause COVID-19 when given as a single booster injection in participants who have previously been vaccinated with a full course of an authorized COVID-19 vaccine.